How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?
Launched by DAVID FRANCO CASTELLANOS · Apr 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how learning to play the piano might impact the development of Alzheimer's disease. The main question the researchers want to answer is whether practicing the piano can help slow down or change the progression of Alzheimer's and other types of dementia. Participants will take piano lessons for four weeks, with a total of 20 sessions, and their progress will be carefully evaluated throughout the trial.
To be eligible for this study, individuals should be experiencing mild to moderate stages of cognitive decline, specifically those categorized in global deterioration stages 2, 3, or 4. Unfortunately, those in other stages or who may not be able to participate fully during the lessons won't be able to join. This trial is not yet recruiting participants, but it aims to gather important information about how engaging in musical activities like playing the piano could potentially benefit brain health and cognitive function in people facing dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients in State of global deterioration Levels GDS 2 3 and 4.
- Exclusion Criteria:
- • Other patients in GDS groups (not 2, 3 and 4)
- • The selected subject does not cooperate during intervention.
About David Franco Castellanos
David Franco Castellanos is a dedicated clinical trial sponsor committed to advancing medical research through innovative and ethical study designs. With a focus on improving patient outcomes, he collaborates with leading healthcare professionals and institutions to ensure rigorous adherence to regulatory standards and best practices in conducting clinical trials. His extensive experience in the pharmaceutical and biotechnology sectors enables him to effectively navigate the complexities of clinical development, fostering an environment of collaboration and transparency. Driven by a passion for scientific discovery, David Franco Castellanos aims to contribute significantly to the evolution of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
León, Castilla Y León, Spain
León, , Spain
Patients applied
Trial Officials
David Franco-Castellanos, Sr
Principal Investigator
Universidad de León
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported